Damian Williams, the United States Attorney for the Southern District of New York, Michael J. Driscoll, the Assistant Director in Charge of the New York Field Office of the Federal Bureau of Investigation (FBI), and Fernando P. McMillan, the Special Agent in Charge of the New York Field Office of the US Food and Drug Administration – Office of Criminal Investigations (FDA-OIC), announced today the filing of a two-count Indictment (the “Indictment”) charging Laura Perryman, the former Chief Executive Officer (CEO) of Stimwave LLC, a Florida-based medical device company, in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain, resulting in millions of dollars in losses to federal healthcare programs. Perryman was arrested this morning in Delray Beach, Florida, and will be presented later today in the United States District Court for the Southern District of Florida.
